| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.4 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.4 |